Connect with us
In March, BioNTech's share price, after rallying to $105, plummeted in two stages to initially $43.66 and then, after an interim recovery to $64.45, to $37....
The recent COVID-19 pandemic has brought together several biotech companies from around the world in an unprecedented effort to find a COVID-19 vaccine that would save...
As the new coronavirus spreads in the world, a number of biotech and pharmaceutical companies are working hard to meet challenges and develop vaccines. There are...
The pharmaceutical and biotechnology industry managers were invited to visit the White House, by the U.S. president, to discuss the development of possible strategies for the...